Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact US
Precision Biologics
Drug Discovery & Development
Overview
Contact US
Contributions
Contributors
Contributions
0 Contributors
1 / 0
1 / 0
1 Contributions
1 / 1
1 / 1
Clinical Trials
Precision Biologics to Announce Development of New Monoclonal Antibody (mAb) PB-223 at SITC, Houston, TX, November 7-8, 2024
Precision Biologics
PR-10-24-NI-78
Nov 07, 2024
No authors found
